Equibles does not estimate personal net worth.
Get an email with a short summary when DENTSPLY SIRONA Inc. publishes a filing, an earnings call transcript or a press release.
Get XRAY alertsMatthew E. Garth is recorded as CFO at DENTSPLY SIRONA Inc. (XRAY) since May 30, 2025. DENTSPLY SIRONA Inc. reported in an 8-K filed November 6, 2025 that Matthew E. Garth was terminated as Executive Vice President and Chief Financial Officer, effective November 5, 2025. The same filing states: “Mr. Garth’s departure was not because of any disagreement with the Company on any matter relating to the Company’s financial statements, internal controls or operations, including accounting principles and practices.” DENTSPLY SIRONA Inc. reported in an 8-K filed May 29, 2025 that Matthew E. Garth was appointed Executive Vice President & Chief Financial Officer, effective May 30, 2025. Minerals Technologies Inc reported in an 8-K filed November 14, 2022 that Matthew E. Garth resigned as Chief Financial Officer, effective November 7, 2022. The proxy statement of DENTSPLY SIRONA Inc. reports total compensation of $3,794,358 for Matthew E. Garth in fiscal 2025, including a base salary of $350,685. DENTSPLY SIRONA Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at DENTSPLY SIRONA Inc. includes Daniel Scavilla (CEO), Donald M. Casey (CEO), John P. Groetelaars (CEO) and 7 others.
“On October 31, 2025, DENTSPLY SIRONA Inc. (the “Company”) determined that Matthew E. Garth will no longer serve as the Executive Vice President and Chief Financial Officer of the Company effective November 5, 2025.”
“Mr. Garth’s departure was not because of any disagreement with the Company on any matter relating to the Company’s financial statements, internal controls or operations, including accounting principles and practices.”
“On May 27, 2025, the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) appointed Matthew E. Garth as the Company’s Executive Vice President & Chief Financial Officer, effective as of May 30, 2025 (the “Effective Date”).”
2025-05-30–present
Start not stated–2025-11-05
XRAY
Medical Instruments & Supplies · Healthcare
CFO
2025-05-30–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | DENTSPLY SIRONA Inc. (XRAY) | Former Executive Vice President, Chief Financial Officer | $350,685 | $3,794,358 |
“Mr. Garth’s departure was not because of any disagreement with the Company on any matter relating to the Company’s financial statements, internal controls or operations, including accounting principles and practices.”
DENTSPLY SIRONA Inc. (XRAY)